TipRanks
Crypto Currents: SEC, CFTC sign MOU for Joint Harmonization Initiative
📈
AI Sentiment
Highly Positive
9/10
- Home
- CNTN
as of 03-19-2026 2:17pm EST
$3.39
$0.11
-3.28%
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
| Founded: | 2017 | Country: | United States |
| Employees: | 3 | City: | BRIDGEWATER |
| Market Cap: | 184.2M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 533.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $3.46 - $5.26 | Next Earning Date: | 02-23-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Latest Canton Strategic Holdings Inc. Common Stock News
CNTN Breaking Stock News: Dive into CNTN Ticker-Specific Updates for Smart Investing
Compare CNTN vs Leading Stocks
See how CNTN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CNTN Canton Strategic Holdings Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.